Association of Antipsychotic Drug Exposure in Pregnancy With Risk of Neurodevelopmental Disorders

Neurodevelopmental Disorders Among Publicly or Privately Insured Children in the United States

(2022) Loreen Straub et al.   JAMA Psychiatry

Association Between Prenatal Exposure to Antipsychotics and Attention-Deficit/Hyperactivity Disorder, Autism Spectrum Disorder, Preterm Birth, and Small for Gestational Age

(2021) Zixuan Wang et al.   JAMA Internal Medicine

Antipsychotic use in pregnancy and risk of attention/deficit-hyperactivity disorder and autism spectrum disorder: a Nordic cohort study

(2021) Óskar Hálfdánarson et al.   Evidence-Based Mental Health

Scientists rise up against statistical significance

(2019) Valentin Amrhein et al.   NATURE

Prevalence and Trends of Developmental Disabilities among Children in the United States: 2009–2017

(2019) Benjamin Zablotsky et al.   PEDIATRICS

Second-generation antipsychotics and pregnancy complications

(2019) Maria Ellfolk et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Atypical antipsychotic use during pregnancy and birth defect risk: National Birth Defects Prevention Study, 1997–2011

(2019) Kayla N. Anderson et al.   SCHIZOPHRENIA RESEARCH

The Safety of Second-Generation Antipsychotics During Pregnancy: A Clinically Focused Review

(2018) Per Damkier et al.   CNS DRUGS

Long-term neurodevelopmental consequences of intrauterine exposure to lithium and antipsychotics: a systematic review and meta-analysis

(2018) Eline M. P. Poels et al.   EUROPEAN CHILD & ADOLESCENT PSYCHIATRY

Risk of Major Malformations in Infants Following First-Trimester Exposure to Quetiapine

(2018) Lee S. Cohen et al.   AMERICAN JOURNAL OF PSYCHIATRY

OUP accepted manuscript

(2018)   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Antipsychotic Medication Use Among Publicly Insured Pregnant Women in the United States

(2017) Yoonyoung Park et al.   PSYCHIATRIC SERVICES

The ASA's Statement onp-Values: Context, Process, and Purpose

(2016) Ronald L. Wasserstein et al.   AMERICAN STATISTICIAN

Neurodevelopmental outcomes in infants exposed in utero to antipsychotics: a systematic review of published data

(2016) Salvatore Gentile et al.   CNS SPECTRUMS

Long-term neurodevelopmental benefits of breastfeeding

(2016) Sari Bar et al.   CURRENT OPINION IN PEDIATRICS

Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses

(2016) Miguel A. Hernán et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations

(2016) Krista F. Huybrechts et al.   JAMA Psychiatry

Meta-analysis in clinical trials revisited

(2015) Rebecca DerSimonian et al.   Contemporary Clinical Trials

Prevalence and trends in the use of antipsychotic medications during pregnancy in the U.S., 2001–2007: a population-based study of 585,615 deliveries

(2013) Sengwee Toh et al.   Archives of Womens Mental Health

Development of a Comorbidity Index for Use in Obstetric Patients

(2013) Brian T. Bateman et al.   OBSTETRICS AND GYNECOLOGY

Harnessing the Medicaid Analytic eXtract (MAX) to Evaluate Medications in Pregnancy: Design Considerations

(2013) Kristin Palmsten et al.   PLoS One

Increasing off-label use of antipsychotic medications in the United States, 1995-2008

(2011) G. C. Alexander et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Questionable Antipsychotic Prescribing Remains Common, Despite Serious Risks

(2010) Bridget M. Kuehn   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data

(2009) Sebastian Schneeweiss et al.   EPIDEMIOLOGY

The Hazards of Hazard Ratios

(2009) Miguel A. Hernán   EPIDEMIOLOGY

Normal Development of Brain Circuits

(2009) Gregory Z Tau et al.   NEUROPSYCHOPHARMACOLOGY

Distinct neurobehavioral consequences of prenatal exposure to sulpiride (SUL) and risperidone (RIS) in rats

(2007) Jing Zuo et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY